Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.